AMERICAN VANGUARD CORP (AVD) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US0303711081
AMERICAN VANGUARD CORP financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 547.31 m USD | 515.11 m USD |
| Gross profit | 120.32 m USD | 147.56 m USD |
| Operating income | -101.56 m USD | -28.30 m USD |
| EBIT | -103.91 m USD | -28.73 m USD |
| Net income | -126.34 m USD | -49.88 m USD |
| Diluted EPS – continuing operations | -4.50 USD | -1.75 USD |
Full history since 1986, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AMERICAN VANGUARD CORP
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
More stocks
- MicroCloud Hologram Inc. (HOLO)
- Amicorp FS (UK) PLC (AMIF.L)
- RADNOSTIX INC (INIS)
- AURA SYSTEMS INC (AUSI)
- Edesa Biotech, Inc. (EDSA)
- Adicet Bio, Inc. (ACET)
- Metagenomi Therapeutics, Inc. (MGX)
- Xos, Inc. (XOS)
- Mono Next Public Company Limited (MONO.BK)
- ATLANTIC AMERICAN CORP (AAME)
- Tonix Pharmaceuticals Holding Corp. (TNXP)
- CervoMed Inc. (CRVO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.